Recombinant Human Deoxyribonuclease I (Guardum Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRecombinant Human Deoxyribonuclease I (Guardum Pharmaceuticals)
Drug Alias NamerhDNase I (Guardum Pharmaceuticals)
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionDeoxyribonuclease 1 stimulants
TargetsDeoxyribonuclease 1
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGuardum Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuardum Pharmaceuticals LLC
Active IndicationsN/A
Inactive IndicationsGraft vs Host Disease

Other Information

ATC CodeN/A
Related LinksN/A